Page 99 - 2021 IDMT Digital

ERYSIPELAS
Introduction:
• 6XSHUILFLDO IRUP RI FHOOXOLWLV FDXVHG E\ EHWD KHPRO\WLF VWUHSWRFRFFL
• &HQWUDO IDFH IUHTXHQWO\ LQYROYHG QRVH
• 8QOHVV SURPSWO\ WUHDWHG local H[WHQVLRQ RI WKH infection can occur (abscess
formation, scarlet fever, pneumonia, skin necrosis, etc.) DQG rarely V\VWHPLF
toxicity.
Subjective:
• 6LJQV DQG 6\PSWRPV
o %ULJKW UHG VSRW WKDW SURJUHVVHV WR D ODUJHU SODTXH
o 3DLQ PDODLVH FKLOOV IHYHU
o )UHTXHQWO\ ORFDWHG RQ QRVH
Objective:
• 3K\VLFDO ([DP
o 9LWDO VLJQV PD\ QRWH IHYHU
o %ULJKW UHG VSRW WKDW SURJUHVVHV WR D WHQVH VKDUSO\ GHPDUFDWHG JOLVWHQLQJ
VPRRWK KRW SODTXH
o /HVLRQ FDQ EH HGHPDWRXV DQG FDQ DGYDQFH ZLWKLQ KRXUV
o 9HVLFOHV RU EXOODH PD\ RFFDVLRQDOO\ GHYHORS
Assessment:
• 'LIIHUHQWLDO
o $FQH YXOJDULV HU\WKHPDWRXV OHVLRQV RSHQ DQG FORVHG FRPHGRQHV
SUHVHQW
o $FQH URVDFHD FKURQLF IDFH GLVRUGHU ZLWK IOXVKLQJ DQG HU\WKHPD
DEVHQFH RI FRPHGRQHV
o /XSXV EXWWHUIO\ SDWWHUQ RI HU\WKHPD DFURVV QRVH
o 3)% LUULWDWLRQ RI WKH VNLQ GXH WR LQJURZLQJ EHDUG KDLUV
Plan:
• 0HGLFDWLRQV
o $QWLELRWLFV
ƒ 3HQLFLOOLQ 9.
ƒ 'LFOR[DFLOOLQ
ƒ 3&1 DOOHUJLF FOLQGDP\FLQ RU HU\WKURP\FLQ
o ,9 DQWLELRWLFV PD\ EH QHFHVVDU\ LI VHYHUH IHYHUV FKLOOV
Patient Education:
• 0RQLWRU IRU VSUHDGLQJ RU IRU V\VWHPLF V\PSWRPV
• )ROORZ 8S $FWLRQV
o )ROORZ FORVHO\ GDLO\ (9$& RU WUDQVIHU LI V\VWHPLF RU ZRUVHQLQJ V\PSWRPV
Preceptor Directive:
• Blue Directive: Contact Preceptor Immediately

[ 98 ]